Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(3)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05569772Phase 3Recruiting

Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes

Role: collaborator

NCT06771440Not ApplicableRecruiting

Support Tool for Antibiotic Allergy deLabeling

Role: collaborator

NCT05061069Not ApplicableCompleted

Vestibular Infants Screening-Flanders

Role: collaborator

NCT04520971Not ApplicableCompleted

Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes

Role: collaborator

NCT05097261Phase 4Recruiting

Ketamine in Acute Brain Injury Patients.

Role: collaborator

NCT04997915Completed

Acute Kidney Injury in Coronavirus Disease-19 (COVID-19) Patients Admitted to the Intensive Care Unit (ICU)

Role: collaborator

All 6 trials loaded